“We aim to be a start-up company with an academic spirit”

Chronic pain and Alzheimer’s are two diseases that plague many people worldwide and seem impossible to cure. However, Huddinge-based company Alzecure is working on developing drugs for both conditions.

The TFS family is growing

TFS HealthScience is a European based CRO company with broad expertise and experiences in the biotech and pharmaceutical sector. The company is growing and the TFS family welcomes new members.

Neutronmöte i Lund samlar hundratals toppforskare

För första gången hålls en konferens knuten till den nya forskningsanläggningen ESS i Lund. Det är Institut Laue-langevin, ILL, i Frankrike och European Spallation Source, ESS, som tillsammans samlar neutronforskare från hela världen.

Amorphous materials take centre stage when Orexo develops new formulations

Swift resolution but with maintained stability. Orexo’s new drug delivery platform tackles the problem of amorphous materials. “Our technology has the positive properties of the material, and it also cracks some of the problems,” says the company’s Research and Development Manager Robert Rönn.

Collaboration for a simpler production of gene therapies launched

A collaboration between universities and companies aims at providing better production methods for the development of gene therapies. The initiative is led by Johan Rockberg, Professor at KTH.

Björn Arvidsson: “We need robust and recognized ecosystems for continued competitiveness”

“We have idea carriers and excellent innovation opportunities, and now we must invest in creating ecosystems that provide them with even better growth opportunities,” Björn Arvidsson writes in a column.

Now it’s settled: The International Vaccine Institute will be located in Stockholm

The International Vaccine Institute, IVI, is establishing itself outside South Korea for the first time. Last week, the Swedish Parliament ratified the agreement, which means that a branch of the institute will be located in Stockholm.

We will now publish more news in English – and offer yet another newsletter

Starting next week, Life Science Sweden will begin offering a newsletter entirely in English.

When carelessness, forgetfulness and coincidence become the researcher’s best friend

Forgetfulness, coincidence and a stroke of luck hardly make up a fruitful method of serious research. Or do they? Actually, a number of important medical advances have come about thanks to completely random incidents and the open-mindedness of scientists who were ready to think outside the box.

Giulia Gaudenzi: Innovation for good

"I challenge the innovator landscape to take a mental leap. Relying on innovation-solely to end inequality is not enough, therefore consciously and purposively – we need to engage bravely with the politics of poverty and scarcity. Even in life sciences", writes Giulia Gaudenzi in a column.

Ny larmrapport: Över en miljon dör på grund av resistens mot antibiotika

En bra bit över en miljon dödsfall i världen orsakades av antibiotikaresistens under 2019, enligt en analys av globala data från 204 länder.

Giulia Gaudenzi: ”Key lessons from global health research”

The world will still face major challenges in the post Covid-19 pandemic, writes Giulia Gaudenzi at the KTH Division of Nanobiotechnology at Scilifelab, in a column.

Otto Cars prisas av regeringen

Får pris för sitt mångåriga och viktiga arbete mot antibiotikaresistens.

Product Specialist at Gradientech AB, Uppsala

Mellanstor reaktor för pilotförsök

Med ett nytt flexibelt system kan man byta reaktionskärl på några minuter.

Sobis blödarkur försenas i USA

FDA kräver mer information och skjuter på PDUFA-genomgången.

Plåster nytt vapen mot resistens

Göteborgsbaserade Abigo bygger ut fabrik som gör antibakteriella förband.

Så hittar du uppköpskandidater

Att investera i bolag på börsen som kan bli uppköpta kan vara en investeringsstrategi att få en snabb avkastning på sitt investerade kapital.

Detta krävs i valideringsprocessen

För att få producera ett läkemedel krävs en dokumenterad valideringsprocess. Det är tillverkarens ansvar att valideringen utförs enligt gällande krav för good manufacturing practice (GMP). Så här går du till väga.

Focusing on Medicon Valley

Copenhagen Capacity and Invest in Skåne are hosting a seminar to promote the geographical area known as Medicon Valley. Some of the 350 life science companies from there will give short presentations to attract partners and investors.

Microwave reactor for use in various synthesis applications

The Monowave 300 microwave reactor offers 850 watts of power for a variety of synthesis applications.

Bioreactor features disposable sensors

The Biostat Cultibag STR line of bioreactors from Sartorius-Stedim features disposable components to reduce risk of contamination.

Double the channels for half the work

The 16-well pipettes from Capp cause less strain for the user when setting up a 384-well plate.

Rapid system for surface hygiene monitoring

The Clean-Trace Surface Testing Instruments are a rapid solution to monitor biological contamination on surfaces in real time to help customers manage their cleaning and protect their samples.